In vitro characterization of hammerhead ribozymes against perforin and fas-ligand RNA.
Du
Z
Z
Diabetes Research Institute, University of Miami School of Medicine, Florida 33136, USA.
Ricordi
C
C
Podack
E
E
Pastori
R L
RL
D000818:Animals; D001483:Base Sequence; D003062:Codon; D018076:DNA, Complementary; D053222:Fas Ligand Protein; D006801:Humans; D008562:Membrane Glycoproteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D016337:RNA, Catalytic / Q000096:biosynthesis*; D013602:T-Lymphocytes, Cytotoxic; D019014:fas Receptor
D003062:Codon; D018076:DNA, Complementary; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D052899:Pore Forming Cytotoxic Proteins; D016337:RNA, Catalytic; D019014:fas Receptor; D054353:Perforin